Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

Recruiting

Phase 1

Gamma GlutamylcysteineSafety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

Sponsor:

Pravat Mandal

Code:

NCT07583251

Conditions

Mild Cognitive Impairment (MCI)

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

Gamma- Glutamylcysteine

Gamma- Glutamylcusteine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-29. This information was provided to ClinicalTrials.gov by Pravat Mandal on 2026-06-03.